Clinical Decision Making regarding Leiomyomata: What We Need in the Next Millenium
نویسندگان
چکیده
منابع مشابه
We need more guidance on shared decision making.
role of the GP has changed. Gone are the days of paternalistic health care. GPs are now leading the way in shared decision making (SDM). To become a member of the Royal College of General Practitioners, a trainee now sits an exam that awards marks for involvement of patients in decision making. Two of the six core competencies of the Royal College of General Practitioners are person-centred car...
متن کاملSurvey nurses’ collaboration in clinical decision making
Introduction: Nurses are the largest care delivering group. They have to judge in clinical ‎setting and by team work detect and solve patients’ problem in nursing function domains. ‎Collaboration in decision making helps this function. ‎ Objective: Present study aims to determine the level of nurses’ collaboration in clinical ‎decision making employed in edu...
متن کاملWomen in clinical research: what we need for progress.
Cardiac Resynchronization Therapy in Women Versus Men: Observational Comparative Effectiveness Study From the National Cardiovascular Data Registry Robbert Zusterzeel, MD; Erica S. Spatz, MD, MHS; Jeptha P. Curtis, MD; William E. Sanders, MD, MBA; Kimberly A. Selzman, MD, MPH; Ileana L. Piña, MD, MPH; Haikun Bao, PhD; Angelo Ponirakis, PhD; Paul D. Varosy, MD; Frederick A. Masoudi, MD, MSPH; Da...
متن کاملNetworking Languages: What We Need and What We Have Networking Languages: What We Need and What We Have
Widespread availability of network access and networked information systems has created a high demand for new generation multi-protocol aware information browsing and presentation tools. In order to support eecient programming and operation for such tools, new networking languages will need to be employed. This study attempts to identify requirements for these networking languages and their env...
متن کاملPatient management and clinical decision making in HBV--aims of therapy and what we can achieve.
International treatment guidelines for hepatitis B emphasize alanine aminotransferase (ALT) and serum HBV DNA thresholds, but strict adherence to these markers might lead to missed opportunities in some patients with acquisition in early life. Clinical trials have used improvement in liver histology, rate of hepatitis B e antigen seroconversion and sustained HBV DNA suppression as primary end p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Environmental Health Perspectives
سال: 2000
ISSN: 0091-6765
DOI: 10.2307/3454315